CRKL and familial pancreatic carcinoma: Interestingly comparative genomic hybridization studies have found amplifications spanning 22q11.21 including CRKL in pancreatic cancers.[20] These amplifications have not been identified in 905 PDA samples according to COSMIC (data base accessed on October 20th 2014).